Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. freshman Avg
|
New words:
accessible, acknowledged, addressing, automatically, bargaining, Boulevard, bribery, broadening, cardiac, certainty, chain, cholesterol, chosen, clarify, Clarifying, Codification, Colin, companion, complicated, compound, conference, configuration, Congenital, constraint, context, contra, debarment, deep, depiction, diligence, driven, drop, EEA, eleven, endemic, eosinophilic, escrow, Ethiopia, explicit, extraordinary, fastest, fertility, fingertip, fragmented, freight, fullest, funder, GDPR, geriatric, GmbH, Hauppauge, hereof, hierarchy, history, Horseblock, illegal, Implantable, imposition, improper, impropriety, inclusion, incremental, indirectly, inflation, Ireland, Jersey, judgement, la, landlord, lessee, lessor, Lumira, LumiraDx, Lutz, manual, manually, Melchior, Myra, nitrocellulose, observable, optical, overallotment, overhaul, para, Parliament, perinatal, pivotal, Plickert, post, Potthoff, PQ, pregnancy, Prequalification, prescribed, problematic, proforma, proven, purely, reclassified, regime, reinforce, respiratory, revoke, Road, robotic, Sherwood, speculative, statistical, stoppage, sublease, sublessee, sublessor, sublet, tiny, traceability, transparent, trend, turnover, Unadjusted, unchartered, underinsured, undue, uniform, unobservable, unrestricted, vacate, vitro, Volker, winning, Workplace
Removed:
acquiring, acting, added, aggregated, aggressively, ago, algorithm, antibody, apparently, assume, attacked, attestation, attractive, avoid, aware, bacteria, bank, barrel, batching, BDO, Biolytical, biomarker, borrow, borrowing, calling, capable, capture, cassette, cell, CEO, CFO, channel, chemical, collectability, commercialized, commonly, communicated, confirm, consecutive, construed, consult, consumed, copy, corporation, counsel, daily, DC, desired, detecting, determinable, digital, dipstick, direct, directed, discrepancy, distinct, distinguish, distributed, distributing, doctor, earlier, EDGAR, encountered, enjoy, enzyme, equal, essentially, expanded, expedite, extend, falciparum, fast, fight, financing, finger, fluid, foil, format, formation, hand, harmful, hospital, IgG, illiquid, immune, immunodiagnostic, Immunoglobulin, incurring, infection, installed, INSTI, intention, invade, investing, Joint, Kissinger, lab, Leishmania, LLP, lost, makeup, manufactured, marked, migration, minute, mobile, NE, neutralize, newest, North, OEM, older, opened, oral, pallidum, par, paragraph, parallel, parasite, partially, partnership, penetrating, persuasive, Peter, plaintiff, plasma, plasmodium, POC, portable, positivity, preventive, primary, procedure, proceeding, processed, produced, prompt, prospective, protein, quantity, recently, reestablish, relied, relief, relocation, remote, rendered, restoration, revised, satisfactorily, scientist, screen, sequestration, serial, show, simultaneously, smaller, solution, specimen, spent, sponsored, StatSure, store, strip, substance, sum, summarized, surface, Syndrome, Task, TBI, team, therapeutic, thereto, thin, threat, Transcriptase, transforming, transmit, travel, Treponema, true, underside, undisclosed, UNICEF, unsuitable, untrained, USA, utility, Vancouver, venue, Washington, wrapper
Filing tables
Filing exhibits
Related press release
Associated CEMI transcripts
CEMI similar filings
Filing view
External links
Exhibit 32
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K (the “Report”) of Chembio Diagnostics, Inc. (the “Company”) for the year ended December 31, 2018, each of the undersigned John J. Sperzel, the President & Chief Executive Officer of the Company, and Neil A. Goldman, the Executive Vice President & Chief Financial Officer of the Company, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to the best of the undersigneds’ knowledge and belief:
(1) This Form 10-K for the year ended December 31, 2018 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in this Form 10-K for the year ended December 31, 2018 fairly presents, in all material respects, the financial condition and results of operations of Chembio Diagnostics, Inc. for the periods presented therein.
Dated: March 18, 2019 | /s/ John J. Sperzel | |
John J. Sperzel | ||
President & Chief Executive Officer |
Dated: March 18, 2019 | /s/ Neil A. Goldman | |
Neil A. Goldman | ||
Executive Vice President & Chief Financial Officer |